Skip to main content
Erschienen in: Obesity Surgery 2/2011

01.02.2011 | Clinical Report

Long-Term Results of Biliopancreatic Diversion with or Without Gastric Preservation for Morbid Obesity

verfasst von: Nicola Crea, Giacomo Pata, Ernesto Di Betta, Francesco Greco, Claudio Casella, Antonio Vilardi, Francesco Mittempergher

Erschienen in: Obesity Surgery | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

We aimed at comparing our long-term results after biliopancreatic diversion (BPD) with or without gastric preservation for morbid obesity. Between 1999 and 2009, we performed 540 BPD: 287 patients (group A) underwent BPD with distal gastric resection (BPD-AHS) and 253 (group B) underwent BPD associated with transitory vertical gastroplasty (TGR) with duodenal switch (DS). The results have been analyzed in terms of weight loss, improvement of comorbidities, and quality of life (Bariatric Analysis and Reporting Outcome System). The mean follow-up was 7.4 ± 2.9 years. One year after surgery, mean initial excess weight loss percentage was 69% for patients in group A (n = 287) and 65% for group B (n = 253); after 2–5 years, it was 74% for patients who underwent BPD-AHS (n = 130) and 75% for patients who underwent BPD-TGR-DS (n = 116); it was 71% and 74% for patients in group A (n = 157) and B (n = 137), respectively, followed up for >5 years (P = 0.27). Among the diabetic patients in both groups (191 patients), 64% discontinued the medication with insulin (P = 0.25), and 98% had stopped oral drugs within 1 year from surgery (P = 0.29). We did not observe deficiencies of vitamins and proteins. The overall incidence of incisional hernias was 38% (P = 0.35). We recorded 13 anastomotic ulcers (2.4%; P = 0.28). BPD represents, in spite of the side effects, an effective technique for treatment of morbid obesity and its associated diseases. Moreover, our results showed that patients who underwent BPD-TGR-DS had slightly better results in terms of postoperative metabolic complications and improvement in quality of life.
Literatur
1.
Zurück zum Zitat Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body mass index and mortality. N Engl J Med. 1998;338:1–7.CrossRefPubMed Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body mass index and mortality. N Engl J Med. 1998;338:1–7.CrossRefPubMed
2.
Zurück zum Zitat Calle EE, Thun MJ, Petrelli MJ, et al. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097–105.CrossRefPubMed Calle EE, Thun MJ, Petrelli MJ, et al. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097–105.CrossRefPubMed
3.
Zurück zum Zitat Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. Diab Care. 2005;28:2406–11.CrossRef Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. Diab Care. 2005;28:2406–11.CrossRef
4.
Zurück zum Zitat O’Brien P, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.CrossRefPubMed O’Brien P, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40.CrossRefPubMed
5.
Zurück zum Zitat Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8.CrossRefPubMed Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8.CrossRefPubMed
6.
Zurück zum Zitat Crea N, Pata G, Di Betta E, Titi A, Mittempergher F. High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications. Obes Surg. 2010 Feb 26. doi:10.1007/s11695-010-0112-4. Crea N, Pata G, Di Betta E, Titi A, Mittempergher F. High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications. Obes Surg. 2010 Feb 26. doi:10.​1007/​s11695-010-0112-4.
7.
Zurück zum Zitat Marceau P, Biron S, Hould FS, et al. Duodenal switch: long-term results. Obes Surg. 2007;17:1421–30.CrossRefPubMed Marceau P, Biron S, Hould FS, et al. Duodenal switch: long-term results. Obes Surg. 2007;17:1421–30.CrossRefPubMed
8.
Zurück zum Zitat Jones KB. Bariatric surgery. Where do we go from here? Int Surg. 2004;89:51–7.PubMed Jones KB. Bariatric surgery. Where do we go from here? Int Surg. 2004;89:51–7.PubMed
9.
Zurück zum Zitat Scopinaro N, Giannetta E, Civalleri D, et al. Bilio-pancreatic by-pass for obesity: II. Initial experience in man. Br J Surg. 1979;66:613–20.CrossRefPubMed Scopinaro N, Giannetta E, Civalleri D, et al. Bilio-pancreatic by-pass for obesity: II. Initial experience in man. Br J Surg. 1979;66:613–20.CrossRefPubMed
10.
Zurück zum Zitat Scopinaro N, Giannetta F, Friedman D, et al. Evolution of biliopancreatic by-pass. Clin Nutr. 1986;5:137–46.CrossRef Scopinaro N, Giannetta F, Friedman D, et al. Evolution of biliopancreatic by-pass. Clin Nutr. 1986;5:137–46.CrossRef
11.
Zurück zum Zitat Scopinaro N, Giannetta F, Civalleri D, et al. Biliopancreatic diversion. In: Griffen WO, Printen KJ, editors. Surgical management of morbid obesity. New York: Marcel Dekker; 1987. p. 93–162. Scopinaro N, Giannetta F, Civalleri D, et al. Biliopancreatic diversion. In: Griffen WO, Printen KJ, editors. Surgical management of morbid obesity. New York: Marcel Dekker; 1987. p. 93–162.
12.
Zurück zum Zitat Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experiences. In: Deitel M, editor. Update: surgery for the morbidly obese patient. Toronto: FD-Communications; 2000. p. 227–58. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experiences. In: Deitel M, editor. Update: surgery for the morbidly obese patient. Toronto: FD-Communications; 2000. p. 227–58.
13.
Zurück zum Zitat Holst JJ. Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterol. 1994;107:1848–55. Holst JJ. Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterol. 1994;107:1848–55.
15.
Zurück zum Zitat Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg. 2004;239:1–11.CrossRefPubMed Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg. 2004;239:1–11.CrossRefPubMed
16.
Zurück zum Zitat Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.CrossRefPubMed Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.CrossRefPubMed
17.
Zurück zum Zitat Marceau P, Biron S, St. Georges R, et al. Biliopancreatic diversion with gastrectomy as surgical treatment of morbid obesity. Ann Surg. 1992;215:387–94.CrossRef Marceau P, Biron S, St. Georges R, et al. Biliopancreatic diversion with gastrectomy as surgical treatment of morbid obesity. Ann Surg. 1992;215:387–94.CrossRef
18.
Zurück zum Zitat Marceau P, Biron S, Lagacè M. Biliopancreatic diversion with distal gastrectomy 250 cm and 50 cm limbs: long term results. Obes Surg. 1995;5:302–7.CrossRefPubMed Marceau P, Biron S, Lagacè M. Biliopancreatic diversion with distal gastrectomy 250 cm and 50 cm limbs: long term results. Obes Surg. 1995;5:302–7.CrossRefPubMed
19.
Zurück zum Zitat Marceau P, Hould FS, Simard S. Biliopancreatic diversion with duodenal switch. Orld J Surg. 1998;22:947–54. Marceau P, Hould FS, Simard S. Biliopancreatic diversion with duodenal switch. Orld J Surg. 1998;22:947–54.
20.
Zurück zum Zitat Vassallo C, Negri L, Della Valle A, et al. Biliopancreatic diversion with transitory gastroplasty preserving duodenal bulb: 3 years experience. Obes Surg. 1997;7:30–3.CrossRefPubMed Vassallo C, Negri L, Della Valle A, et al. Biliopancreatic diversion with transitory gastroplasty preserving duodenal bulb: 3 years experience. Obes Surg. 1997;7:30–3.CrossRefPubMed
21.
Zurück zum Zitat Cossu ML, Noya G, Tonolo GC, et al. Duodenal switch without gastric resection: results and observations after 6 years. Obes Surg. 2004;14:1354–9.CrossRefPubMed Cossu ML, Noya G, Tonolo GC, et al. Duodenal switch without gastric resection: results and observations after 6 years. Obes Surg. 2004;14:1354–9.CrossRefPubMed
22.
Zurück zum Zitat Anonymous. Gastrointestinal surgery for morbid obesity: National Institute of Health Consensus Development Conference Statement. Am J Clin Nutr, 1992; 55:615S–19S. Anonymous. Gastrointestinal surgery for morbid obesity: National Institute of Health Consensus Development Conference Statement. Am J Clin Nutr, 1992; 55:615S–19S.
23.
Zurück zum Zitat Mittempergher F, Di Betta E, Crea N, et al. Our experience in selecting patients for bariatric surgery. Ann Ital Chir. 2007;78:487–92.PubMed Mittempergher F, Di Betta E, Crea N, et al. Our experience in selecting patients for bariatric surgery. Ann Ital Chir. 2007;78:487–92.PubMed
24.
Zurück zum Zitat Oria HE, Moorehead MK. Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg. 1998;8:487–99.CrossRefPubMed Oria HE, Moorehead MK. Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg. 1998;8:487–99.CrossRefPubMed
25.
Zurück zum Zitat Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead–Ardelt–Gattinger quality of life questionnaire II. Obes Surg. 2003;13:684–92.CrossRefPubMed Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead–Ardelt–Gattinger quality of life questionnaire II. Obes Surg. 2003;13:684–92.CrossRefPubMed
26.
Zurück zum Zitat Marinari GM, Murelli F, Camerini G, et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg. 2004;14:325–8.CrossRefPubMed Marinari GM, Murelli F, Camerini G, et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg. 2004;14:325–8.CrossRefPubMed
27.
28.
Zurück zum Zitat Van Hee R. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg. 2004;28:435–44.CrossRefPubMed Van Hee R. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg. 2004;28:435–44.CrossRefPubMed
29.
Zurück zum Zitat Mittempergher F, Di Betta E, Nascimbeni R, et al. Comparison between a bilio-pancreatic diversion with or without gastroresection after 2 years of follow-up in the treatment of the pathological obesity. Ann Ital Chir. 2008;79:241–6.PubMed Mittempergher F, Di Betta E, Nascimbeni R, et al. Comparison between a bilio-pancreatic diversion with or without gastroresection after 2 years of follow-up in the treatment of the pathological obesity. Ann Ital Chir. 2008;79:241–6.PubMed
30.
Zurück zum Zitat Di Betta E, Mittempergher F, Nascimbeni R, et al. Outcome of duodenal switch with a transitory vertical gastroplasty, in super-super-obese patients in an 8-year series. Obes Surg. 2008;18:182–6.CrossRefPubMed Di Betta E, Mittempergher F, Nascimbeni R, et al. Outcome of duodenal switch with a transitory vertical gastroplasty, in super-super-obese patients in an 8-year series. Obes Surg. 2008;18:182–6.CrossRefPubMed
31.
Zurück zum Zitat Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18:1035–8.CrossRefPubMed Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18:1035–8.CrossRefPubMed
32.
Zurück zum Zitat Larrad-Jimenez A, Diaz-Guerra CSC, de Cuadros Borrajo P, et al. Short-, mild- and long-term results of Larrad biliopancreatic diversion. Obes Surg. 2007;17:202–10.CrossRefPubMed Larrad-Jimenez A, Diaz-Guerra CSC, de Cuadros Borrajo P, et al. Short-, mild- and long-term results of Larrad biliopancreatic diversion. Obes Surg. 2007;17:202–10.CrossRefPubMed
33.
Zurück zum Zitat Gueda ME, del Amo DA, Solanas JAG, et al. Results of biliopancreatic diversion after five years. Obes Surg. 2004;14:766–72.CrossRef Gueda ME, del Amo DA, Solanas JAG, et al. Results of biliopancreatic diversion after five years. Obes Surg. 2004;14:766–72.CrossRef
34.
Zurück zum Zitat Friedman D, Traverso G, Adami E, et al. Incisional hernias following biliopancreatic diversion. Obes Surg. 1996;6:304. Abst 21. Friedman D, Traverso G, Adami E, et al. Incisional hernias following biliopancreatic diversion. Obes Surg. 1996;6:304. Abst 21.
35.
Zurück zum Zitat Sugerman HJ, Kellum Jr JM, Reines HD, et al. Greater risk of incision hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg. 1996;171:80–4.CrossRefPubMed Sugerman HJ, Kellum Jr JM, Reines HD, et al. Greater risk of incision hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg. 1996;171:80–4.CrossRefPubMed
36.
Zurück zum Zitat Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12:241–4.CrossRefPubMed Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12:241–4.CrossRefPubMed
37.
Zurück zum Zitat Fox R, Fox K. Vertical banded gastroplasty and distal gastric bypass as primari procedures: a comparison. Obes Surg. 1996;6:421–5.CrossRefPubMed Fox R, Fox K. Vertical banded gastroplasty and distal gastric bypass as primari procedures: a comparison. Obes Surg. 1996;6:421–5.CrossRefPubMed
38.
Zurück zum Zitat Totté E, Hendrickx L, van Hee R. Biliopancreatic diversion for treatment of morbid obesity: experience in 180 consecutive cases. Obes Surg. 1999;9:161–5.CrossRefPubMed Totté E, Hendrickx L, van Hee R. Biliopancreatic diversion for treatment of morbid obesity: experience in 180 consecutive cases. Obes Surg. 1999;9:161–5.CrossRefPubMed
39.
Metadaten
Titel
Long-Term Results of Biliopancreatic Diversion with or Without Gastric Preservation for Morbid Obesity
verfasst von
Nicola Crea
Giacomo Pata
Ernesto Di Betta
Francesco Greco
Claudio Casella
Antonio Vilardi
Francesco Mittempergher
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 2/2011
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0333-6

Weitere Artikel der Ausgabe 2/2011

Obesity Surgery 2/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.